TABLE 3.
Univariable and multivariable analyses of factors associated with hospital mortality in patients with SARS-COV-2 infectiona
| Variable | Univariable analysis |
Multivariable analysis |
Multivariable adjusted according to propensity score |
|||
|---|---|---|---|---|---|---|
| OR (95% CI) | P value | OR (95% CI) | P value | OR (95% CI) | P value | |
| Age | 1.12 (1.08–1.15) | <0.001 | 1.13 (1.08–1.18) | 0.048 | 1.11 (1.05–1.18) | <0.001 |
| Age-adjusted Charlson score | 1.34 (1.21–1.49) | <0.001 | ||||
| Underlying medical conditions | 3.6 (1.5–8.6) | 0.002 | ||||
| High blood pressure | 3.1 (1.8–5.3) | <0.001 | ||||
| Ischemic heart disease | 3.1 (1.7–5.4) | <0.001 | ||||
| Diabetes | 2.8 (1.6–4.9) | <0.001 | ||||
| Dyslipidemia | 2.0 (1.2–3.4) | 0.011 | ||||
| Cardiovascular risk factors | 2.5 (1.4–5.7) | 0.003 | ||||
| Chronic kidney disease | 9.2 (4.1–20.5) | <0.001 | 29.13 (7.93–107.03) | <0.001 | 43.28 (6.90–273.87) | <0.001 |
| Onco-hematologic disease | 2.5 (1.3–4.6) | 0.005 | ||||
| Transplant (SOT/SCT) | 8.9 (2.5–32.6) | 0.001 | ||||
| Neurologic disease | 3.1 (1.6–6.1) | 0.002 | ||||
| Hydroxychloroquine | 0.13 (0.28–0.59) | 0.013 | ||||
| Lopinavir-ritonavir | 0.42 (0.25–0.70) | 0.001 | ||||
| PaO2/FiO2 (on D0) | 0.99 (0.98–0.99) | <0.001 | ||||
| SatO2/FiO2 (on D0) | 0.99 (0.991–0.998) | <0.001 | ||||
| ARDS | 1.77 (1.01–3.09) | 0.046 | 2.00 (1.14–3.51) | 0.015 | 1.17 (0.51–2.67) | 0.714 |
| Lactate dehydrogenase (on D0) | 1.003 (1.001–1.005) | 0.001 | 1.004 (1.00–1.01) | 0.002 | 1.001 (1.00–1.01) | 0.012 |
| d-Dimer (on D0) | 1.04 (1.00–1.07) | 0.036 | ||||
| C-reactive protein (on D0) | 1.004 (1.001–1.008) | 0.011 | ||||
| Steroid treatment | 0.51 (0.27–0.96) | 0.044 | 0.34 (0.12–0.99) | 0.048 | 0.19 (0.05–0.74) | 0.016 |
SOT, solid organ transplantation; SCT, stem cell transplantation; D0, day 0; PaO2/FiO2, arterial oxygen tension/inspiratory oxygen fraction; SatO2/FiO2, oxygen saturation/inspiratory oxygen fraction; ARDS, acute respiratory distress syndrome.